Not applicableLooking for participantsNCT05263570
What this trial is testing
The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.
Who this might be right for
Breast Cancer
Shengjing Hospital 200